Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

Share Price is delayed by 15 minutes
Get Live Data
76.60    2.20 (2.96%)
Bid:
76.40
Ask:
76.80
Spread: 0.40 (0.524%)
Market Cap: €12.24b
KYGA Live PriceLast checked at - London Stock Exchange

Intraday Kerry Share Chart

Launch of Share Buyback Programme

17 Feb 2026 07:30

RNS Number : 2371T
Kerry Group PLC
17 February 2026
 

 

 

17 February 2026

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP PLC

Kerry Group plc announces €300m share buyback programme.

On 17 February 2026, Kerry Group plc ("Kerry" or the "Company") announced its intention to launch a new share buyback programme of up to €300 million (the "Buyback Programme"). The Buyback Programme is underpinned by the Group's strong balance sheet and cash flow and is aligned to Kerry's Capital Allocation Framework.

Kerry announces that, pursuant to the Buyback Programme, it has entered into non-discretionary instructions with J&E Davy ("Davy") to purchase up to €300 million of Kerry's A Ordinary Shares of €0.125 each (the "Shares") on its behalf, and to make trading decisions under the Buyback Programme independently of Kerry in accordance with certain pre-set parameters.

The Buyback Programme will commence on 17 February 2026 and will end on 31 December 2026 at the latest. All Shares will be purchased by Davy on the Company's behalf (on a riskless principal basis) on Euronext Dublin for subsequent repurchase by the Company on Euronext Dublin.

The purpose of the Buyback Programme is to reduce the share capital of the Company and as such, the Company will cancel any Shares repurchased.

The Buyback Programme will be conducted within certain pre-set parameters and within the limitations of the authority granted at Kerry's Annual General Meeting on 1 May 2025 ("2025 AGM") up to a maximum number of 16,489,274 Shares. Following the expiry of the 2025 AGM repurchase authority, the continuation of the Buyback Programme will be conditional on shareholder approval of an authority to repurchase Shares at the AGM to be held on 30 April 2026.

The Buyback Programme will be conducted in accordance with the relevant provisions of the Market Abuse Regulation 596/2014/EU ("MAR" and including MAR as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) and the Commission Delegated Regulation (EU) 2016/1052 (including as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) as well as the rules of the Central Bank of Ireland.

Any repurchase of Shares will be announced no later than 7:30 am on the business day following the calendar day on which the repurchase occurred.

 

CONTACT INFORMATION

GROUP SECRETARY

Ronan Deasy

+353 66 7182000 | GroupCoSec@kerry.ie

WEBSITE

www.kerry.com

 

​Kerry Group | Regulatory Announcement 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPURWPUPQGMQ
Date   Source Headline
3rd Jan 202311:13 amRNSTotal Voting Rights
13th Dec 20222:31 pmRNSDirectorate Change
1st Dec 202210:17 amRNSTotal Voting Rights
1st Nov 202211:59 amRNSTotal Voting Rights
27th Oct 20227:00 amRNSQ3 Interim Management Statement 2022
7th Oct 20227:00 amRNSKerry Increases its Stake in Proparent B.V.
3rd Oct 202210:13 amRNSTotal Voting Rights
5th Sep 20221:04 pmRNSDirector/PDMR Shareholding
1st Sep 202210:08 amRNSTotal Voting Rights
30th Aug 20222:02 pmRNSKerry Acquisition Announcement
2nd Aug 202210:09 amRNSDirector/PDMR Shareholding
2nd Aug 20229:00 amRNSTotal Voting Rights
29th Jul 20227:00 amRNSKerry Group Interim Management Report 2022
1st Jul 20228:54 amRNSBlock listing Interim Review
1st Jul 20228:40 amRNSTotal Voting Rights
20th Jun 202210:23 amRNSHolding(s) in Company
1st Jun 202210:03 amRNSTotal Voting Rights
3rd May 202212:57 pmRNSTotal Voting Rights
28th Apr 20224:32 pmRNSDirectorate Change
28th Apr 20224:29 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 Interim Management Statement 2022
4th Apr 20221:42 pmRNSStatement re Russian and Belarus Operations
1st Apr 202211:22 amRNSTotal Voting Rights
25th Mar 202212:55 pmRNSNotice of AGM
16th Mar 20221:50 pmRNSHolding(s) in Company
16th Mar 20221:39 pmRNSDirector/PDMR Shareholding
15th Mar 20224:45 pmRNSDirector/PDMR Shareholding
11th Mar 20224:03 pmRNSDirector/PDMR Shareholding
11th Mar 20223:59 pmRNSDirector/PDMR Shareholding
11th Mar 20223:55 pmRNSDirector/PDMR Shareholding
11th Mar 202212:13 pmRNSAnnual Financial Report
1st Mar 20229:50 amRNSTotal Voting Rights
25th Feb 20223:14 pmRNSDirector/PDMR Shareholding
16th Feb 20227:00 amRNSPreliminary Statement of Results 31 December 2021
15th Feb 202211:29 amRNSNotice of Results and AGM
15th Feb 20227:00 amRNSKerry – strategic biotechnology acquisitions
1st Feb 20222:21 pmRNSTotal Voting Rights
4th Jan 20223:00 pmRNSBlock listing Interim Review
4th Jan 202212:00 pmRNSTotal Voting Rights
13th Dec 202110:31 amRNSDirectorate Change
9th Dec 202112:17 pmRNSDirector/PDMR Shareholding
1st Dec 202112:26 pmRNSTotal Voting Rights
29th Nov 20211:28 pmRNSDirector/PDMR Shareholding
24th Nov 20215:41 pmRNSKerry - EUR750m Sustainability-Linked Notes
1st Nov 202111:20 amRNSTotal Voting Rights
27th Oct 20217:00 amRNSQ3 Interim Management Statement 2021
13th Oct 20217:00 amRNSKerry Strategic Update – Capital Markets Day
1st Oct 20219:20 amRNSTotal Voting Rights
27th Sep 20217:00 amRNSKerry Completes Sale of Meats & Meals Business
14th Sep 20217:00 amRNSKerry completes acquisition of Niacet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.